ResearchSafe

GlyNAC vs Humanin

A side-by-side research comparison of GlyNAC and Humanin across mechanism, dosing, half-life, benefits, side effects and research status.

Comparison table

AttributeGlyNACHumanin
Full nameGlycine + N-AcetylcysteineHumanin (HN) Mitochondrial-Derived Peptide
CategoryAnti-AgingAnti-Aging
StatusOTC supplement combinationResearch compound
MechanismGlycine and NAC (a cysteine donor) are the rate-limiting precursors for glutathione. Replenishing both restores intracellular glutathione, lowers oxidative stress, improves mitochondrial fuel oxidation, and reduces inflammation and insulin resistance.Binds IGFBP-3, BAX, and trimeric receptor (CNTFR/WSX-1/gp130) to activate STAT3. Inhibits mitochondrial apoptosis and provides neuroprotection.
Molecular weightGlycine 75.07 Da / NAC 163.19 Da2,687 Da
Half-lifeGlycine ~1 h; NAC ~6 h4-6 hours
BioavailabilityGlycine high; NAC ~4-10% but effective as cysteine donorModerate (SubQ)
Typical doseGlycine ~100 mg/kg + NAC ~100 mg/kg per day1-5 mg
FrequencySplit 1-2x daily3-5x per week
RouteOral (powder or capsule)Subcutaneous

GlyNAC reported benefits

  • Restores glutathione levels
  • Improves mitochondrial function
  • Lowers oxidative stress and inflammation
  • Better insulin sensitivity
  • Improved strength and cognition (elderly)
  • Sleep support (glycine)

Humanin reported benefits

  • Neuroprotection against amyloid-beta
  • Anti-apoptotic
  • Improved insulin sensitivity
  • Cardioprotection
  • Cellular stress resistance

Related comparisons

Research and educational reference only. Not medical advice.